Clinical Study of YS110 in Patients With Malignant Pleural Mesothelioma
Status:
Completed
Trial end date:
2020-02-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine tolerability, safety, and pharmacokinetics of YS110
intravenous administration in patients with malignant pleural mesothelioma and to
preliminarily examine the anti-tumor effect of YS110.